Bio-Rad Laboratories, Inc.
Could not find a ticker for this position, may be a filing error
A maker of instruments, reagents, and consumables for life-science research and clinical diagnostics, Bio-Rad's products help labs separate and analyze biological materials and run diagnostic tests. Founded in 1952 by UC Berkeley graduates David and Alice Schwartz, the company began in a Quonset hut in Berkeley, California. Its name is a portmanteau of its first product lines: biochemicals and radiochemicals.
Granted 9.8K
Granted 1.7K
Granted 1.9K
Granted 2.6K
Granted 1.9K
Granted 239
Granted 407
Granted 954
Granted 407
Granted 407
Granted 407
Granted 1.7K · Sold 699.87
Granted 1.2K · Sold 550
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Schwartz Norman DChairman & CEO, Director, 10% owner · 4 transactions | +0.1% | 5.24M | 9.8K | — | — |
| Corey ColleenEVP, Global Human Resources · 4 transactions | +4.8% | 19.6K | 1.7K | — | — |
| Evran SedatEVP, Global Supply Chain · 4 transactions | +116.1% | 2.6K | 1.9K | — | — |
| Lakkaraju Roop KalyanEVP, Chief Financial Officer · 4 transactions | +203.3% | 2.6K | 2.6K | — | — |
| DiVincenzo Jonathan P.President & COO · 2 transactions | — | 1.9K | 1.9K | — | — |
| Allison SchwartzDirector · 4 transactions | +11.6% | 1.5K | 239 | — | — |
| Hinckley Greg KDirector · 1 transaction | — | 1.2K | 407 | — | — |
| Enloe Courtney CEVP, General Counsel & Sec · 4 transactions | +479.5% | 749.78 | 954 | — | — |
| Edwards Jeffrey LDirector · 1 transaction | +132.1% | 715 | 407 | — | — |
| Pei Melinda LitherlandDirector · 1 transaction | +132.1% | 715 | 407 | — | — |
| Pinkston Arnold ADirector · 1 transaction | +132.1% | 715 | 407 | — | — |
| Barry JamesEVP, President, LSG · 5 transactions | +247.8% | 509.68 | 1.7K | — | 699.87 |
| Engelhardt Eva AnetteEVP, President, CDG · 3 transactions | +120.4% | 346 | 1.2K | — | 550 |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last year: -1.2K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.